PPARG and type 2 diabetes mellitus: Our analyses also indicated that rs11709077 and rs1801282 on PPARG negatively affect the expression of SYN2 (Synapsin II) in skeletal muscle and in whole blood (Table 2, Figure 1); however, there is not yet any evidence connecting SYN2 with T2D or AML.